Showing results (331-340 of 357) with videos related to

Sort By:
Pageof 36
Cancer Chemotherapy and Pharmacology|January 29, 1999
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)Q Dong, S P Johnson, O M Colvin, et al.
The Journal of Pediatrics|December 1, 1996
Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxisA B Bjornson, J M Falletta, J I Verter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumorsJ H Sampson, L E Crotty, S Lee, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II StudyR P Kadota, L E Kun, J W Langston, et al.
British Journal of Cancer|July 3, 2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugsD M Ashley, C D Riffkin, M M Lovric, et al.
British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PETD N Jones, G B McCowage, H D Sostman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumorsM L Graham, J E Herndon, J R Casey, et al.
Medical and Pediatric Oncology|December 24, 1997
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomasG B McCowage, H S Friedman, A Moghrabi, et al.
Journal of Medicinal Chemistry|February 16, 1996
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular sizeL F Kuyper, D P Baccanari, M L Jones, et al.
Pageof 36